Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Mapping pathophysiological features of breast tumors by MRI at high spatial resolution

Abstract

Magnetic resonance imaging (MRI) is a noninvasive method that reveals anatomical details in vivo and detects lesions for diagnosis. Although standard breast MRI cannot clearly delineate breast cancer, contrast-enhanced MRI enables the detection of breast masses with high sensitivity1,2. Dynamic studies demonstrated that malignant lesions were characterized by a faster signal enhancement rate than benign ones3. Dynamic MRI of human breast cancer in mice revealed high heterogeneity in the distribution of contrast-enhanced curves and derived pathophysiological features, indicating the importance of high spatial resolution4,5. With clinical MRI, it is difficult to achieve simultaneously high spatial and temporal resolution. In previous dynamic studies, the emphasis was on high temporal resolution and mainly empiric analyses6–12. We describe here a new model-based method that optimizes spatial resolution by using only three time points, and yet characterizes tumor heterogeneity in terms of microvascular permeability and extracellular fraction. Mapping these pathophysiological features may aid diagnosis and prognosis assessment, while the high spatial resolution may improve the capacity to detect smaller lesions. The method was tested in human breast tumors implanted in mice and in a limited number of benign and malignant breast lesions of patients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Harms, S.E. & Flaming, D.P. MR imaging of the breast. J. Magn. Reson. Imaging 3, 277–283 (1993).

    Article  CAS  Google Scholar 

  2. Heywang-Kobrunner, S.H. Contrast-enhanced magnetic resonance imaging of the breast. Invest. Radiol. 29, 94–104 (1994).

    Article  CAS  Google Scholar 

  3. Kaiser, W.A. & Zeitler, E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Radiology 170, 681–686 (1989).

    Article  CAS  Google Scholar 

  4. Furman-Haran, E., Margalit, R., Maretzek, A.F. & Degani, H. Angiogenic response of MCF7 human breast cancer to hormonal treatment: Assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution. J. Magn. Reson. Imaging 6, 195–202 (1996).

    Article  CAS  Google Scholar 

  5. Furman-Haran, E., Margalit, R., Grobgeld, D. & Degani, H. Dynamic contrast enhanced magnetic resonance imaging reveals stress induced angiogenesis in MCF7 human breast tumors. Proc. Natl. Acad. Sci. USA 93, 6247–6251 (1996).

    Article  CAS  Google Scholar 

  6. Frouge, C., Guinebretiere, J.-M., Contesso, G., DiPaola, R. & Blery, M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumour angiogenesis. Invest Radiol. 29, 1043–1049 (1994).

    Article  CAS  Google Scholar 

  7. Buckley, D.L., Kerslake, R.W., Blackband, S.J. & Horsman, A. Quantitative analysis of multislice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magn. Reson. Med. 32, 646–65 (1994).

    Article  CAS  Google Scholar 

  8. Hoffmann, U., Brix, G., Knopp, M.V., Heb, T. & Lorenz, W.J. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography. Magn. Reson. Med. 33, 506–514 (1995).

    Article  CAS  Google Scholar 

  9. Hulka, C.A. et al. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging. Radiology 197, 33–38 (1995).

    Article  CAS  Google Scholar 

  10. Tofts, P.S., Berkowitz, B. & Schnall, M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn. Reson. Med. 33, 564–568 (1995).

    Article  CAS  Google Scholar 

  11. Lucas-Qesada, F.A., Sinha, U. & Sinha, S. Segmentation strategies for breast tumors from dynamic MR images. J. Magn. Reson. Imaging 6, 753–763 (1996).

    Article  Google Scholar 

  12. Keltz, F., Santyr, G.E., Cron, G.O. & Mongin, S.J. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J. Magn. Reson. Imaging 6, 743–752 (1996).

    Article  Google Scholar 

  13. Larsson, H.B.W. et al. Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 16, 117–131 (1990).

    Article  CAS  Google Scholar 

  14. Brix, G. et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Computer Assisted Tomogr. 15, 621–628 (1991).

    Article  CAS  Google Scholar 

  15. Tofts, P.S. & Kermode, A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 17, 357–367 (1991).

    Article  CAS  Google Scholar 

  16. Furman, E., Margalit, R., Bendel, P., Horowitz, A. & Degani, H. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun. 3, 287–297 (1991).

    Article  CAS  Google Scholar 

  17. Folkman, J. Tumor angiogenesis. Advances Cancer Res. 43, 175–203 (1985).

    Article  CAS  Google Scholar 

  18. Weidner, N., Semple, J.P., Wilch, W.R. & Folkman, J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1–8 (1991).

    Article  CAS  Google Scholar 

  19. Weidner, N. et al. Tumour angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. 84, 1875–1887 (1992).

  20. Degani, H. et al Evaluation of breast cancer therapy with contrast enhanced MRI at high spatial resolution. J. Magn. Reson. Imaging 4, 116 (1994).

    Google Scholar 

  21. Weidmann, H.J., Laniado, M. & Mutzel, W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. Med. NMR 16, 167–172 (1984).

    Google Scholar 

  22. Poon, C.S., Bronskill, M.J., Hemkelman, R.M. & Boyd, N.F. Quantitative magnetic resonance imaging parameters and their relationship to mammographic pattern. J. Natl. Cancer Inst. 84, 777–781 (1992).

    Article  CAS  Google Scholar 

  23. Lauffer, R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem. Rev. 87, 901–927 (1987).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Degani, H., Gusis, V., Weinstein, D. et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 3, 780–782 (1997). https://doi.org/10.1038/nm0797-780

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0797-780

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing